CD26+ NFs enhanced the invasive properties of tumor cells via matrix metalloproteinase (MMP) activity and co-cultures of CD26+ NFs and tumor cells recruited CD11b+ myeloid cells in a CXCL12-dependent manner. The gene discussed is DPP4; the disease is neoplasm.